Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces the ...

Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...

In a European study, higher consumption of fruits, vegetables, legumes, and potatoes was associated with a reduced risk of ...

Amgen and Zai Lab have reported that the Phase III FORTITUDE-101 trial, assessing bemarituzumab in combination with ...

Buoyed by positive gains for shares of Amgen and Merck, the Dow Jones Industrial Average is climbing Tuesday morning. Supported by world-class markets data from Dow Jones and FactSet, and partnering ...

In a detail-thin announcement, Amgen said that adding bemarituzumab to chemotherapy improved overall survival, though ...

Amgen acquired Five Prime in 2021 on the back of the phase 2 FIGHT trial of bemarituzumab, which achieved significant ...

Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

Detroit Lions legend Barry Sanders has let a terrifying personal experience guide him to advocate for a very important cause ...

Emerging oligonucleotides and gene editing therapies offer greater precision, long-term efficacy, and improved adherence in ...

The investment signals confidence in Levelpath's fast growth and its potential to disrupt a market dominated by legacy ...